Latest Pipeline Advancement Expands Therapeutic Flexibility of System One Download image LAWRENCE, Mass., Feb. 21, 2013 /PRNewswire/ — NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced CE Mark approval for new high flow capabilities with…
published: February 22, 2013 in: Approval/Clearance, Technology